Douglas R Adkins

20PUBLICATIONS
188CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 31, 2026
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|Apr 01, 2026
Systemic Treatment of Thyroid Cancer: ASCO Guideline.

Nabil F Saba, Nofisat Ismaila, Douglas Adkins

|Feb 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.

Jong Chul Park, David Berz, Manish R Sharma

|Jan 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors.

Jong Chul Park, David Berz, Manish R Sharma

|Nov 03, 2025
Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer.

Seka Lazare, Zhuosheng Gu, Noah Earland

|Aug 20, 2025
Olaparib, Pembrolizumab, and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase II Trial.

Douglas Adkins, Jessica C Ley, Jingxia Liu

Pageof 4

Frequent Collaborators

4 joint publications

Sidharth V Puram

3 joint publications

Patrik Pipkorn

3 joint publications

Nofisat Ismaila

3 joint publications

Barbara Burtness